Metformin Cost in Mississippi 2026: Cash Price, Medicaid, and Discount Options

What Does Metformin Actually Cost in Mississippi Right Now?

The average cash-pay price for generic metformin hydrochloride at Mississippi retail pharmacies in 2026 is approximately $8 per month for a standard 500 mg twice-daily regimen. That figure sits far below the $40 per month manufacturer list price for packaged generics, and it can drop lower still when discount programs are applied. A 30-day supply of metformin 500 mg (60 tablets) at Walmart locations in Mississippi rings up at $4 under the chain's legacy $4 generic list, making it one of the cheapest oral medications available anywhere in the country.

Price varies by formulation. Immediate-release (IR) tablets are the cheapest option. Extended-release (ER or XR) versions, sometimes branded as Glucophage XR, carry a modest premium because of the more complex manufacturing process. In Mississippi, a 30-day supply of generic metformin ER 500 mg runs roughly $10, $15 cash pay without any coupon, compared to $4, $8 for IR tablets at the same pharmacies.

Why the List Price and the Street Price Are So Different

The $40 manufacturer list price reflects the wholesale acquisition cost before pharmacy markups and before any rebate or discount is applied. Generic metformin has been off-patent for decades, and competition among manufacturers is intense. The FDA's Orange Book lists more than 30 approved generic manufacturers of metformin hydrochloride tablets as of early 2026. That competitive pressure forces retail prices far below list. Patients who pay cash and skip insurance billing often pay less than those who run a claim through a high-deductible plan, because pharmacy dispensing fees can exceed the actual ingredient cost on very cheap generics.

One 2021 analysis published in JAMA Internal Medicine found that cash prices at pharmacies using GoodRx coupons were lower than insurance copays for 23% of common generic drugs, with metformin among the most extreme examples [1]. Knowing this matters practically. Running the prescription through insurance is not always the cheapest move.

Does Mississippi Medicaid Cover Metformin?

Mississippi Medicaid does not currently list metformin as a covered benefit across all eligibility categories and indications. Patients enrolled in Mississippi Division of Medicaid (DOM) fee-for-service plans may find metformin absent from the preferred drug list (PDL) for certain diagnoses, particularly prediabetes and off-label longevity use. Coverage for type 2 diabetes treatment through managed care organizations (MCOs) that contract with Mississippi DOM varies by plan and is subject to prior-authorization requirements.

This coverage gap matters in a state where the CDC places the diagnosed diabetes prevalence at 14.4% of adults, the second-highest rate in the nation [2]. Patients with confirmed type 2 diabetes who are enrolled in Mississippi Medicaid should ask their prescribing clinician to submit a prior-authorization request with ICD-10 code E11 (type 2 diabetes mellitus) clearly documented. Approval rates for PA requests improve substantially when A1C values above 7.0% are included in the clinical notes.

Patients on Medicare Part D fare better. Metformin IR and ER are Tier 1 drugs on most Part D formularies, with copays ranging from $0 to $5 per month depending on the specific plan. Mississippi residents enrolled in a Medicare Advantage plan should verify their plan's formulary at Medicare.gov before assuming coverage.

The American Diabetes Association's 2024 Standards of Care list metformin as a first-line pharmacologic agent for type 2 diabetes management, describing it as having "a long track record of efficacy, safety, and low cost" [3]. That guideline endorsement is often the lever a clinician needs to support a Medicaid PA request.

Cheapest Ways to Get Metformin in Mississippi

Several concrete options exist for Mississippi residents who need to minimize out-of-pocket cost.

Walmart $4 Generic Program. Walmart's in-store pharmacy charges $4 for a 30-day supply and $10 for a 90-day supply of metformin IR at Mississippi locations. No membership card, no coupon code, and no insurance is required. The program covers metformin 500 mg and 850 mg tablets; 1 to 000 mg tablets and ER formulations are not always included, so confirm with the specific store.

GoodRx and RxSaver Coupons. GoodRx coupons bring the cash price of metformin 500 mg (60 tablets) to as low as $4, $6 at Walgreens, CVS, Kroger, and Rite Aid locations in Mississippi. RxSaver and NeedyMeds offer comparable discounts. These coupons cannot be combined with insurance, but they can be used without any enrollment process. Present the coupon code at the pharmacy counter before the claim is processed.

Mark Cuban's Cost Plus Drugs. Cost Plus Drugs (costplusdrugs.com) lists metformin hydrochloride 500 mg at roughly $5 for a 90-day supply including shipping. The platform ships to Mississippi, requires a valid prescription, and accepts no insurance, meaning the listed price is the actual price. For patients willing to use mail-order, this is frequently the lowest total-cost option for metformin IR.

Compounded Metformin via 503A Pharmacies. In Mississippi, state pharmacy law permits 503A compounding pharmacies to prepare patient-specific formulations of metformin when a licensed prescriber writes a valid, patient-specific prescription. Some 503A telehealth pharmacy programs bundle the cost of compounded metformin into a subscription or membership fee, effectively making the drug itself $0 per month. This path is not appropriate for every patient. Compounded formulations are not FDA-approved drug products, so they lack the clinical equivalence guarantee of an FDA-approved generic. They may be appropriate when a patient requires a non-standard dose, a specific delivery form, or cannot access a retail pharmacy.

Patient Assistance Programs. Bristol-Myers Squibb (BMS) previously marketed Glucophage and maintains a patient assistance program through its Together on Diabetes initiative for patients who meet income criteria. Generic manufacturer programs are less common, but NeedyMeds.org maintains a searchable database of state-specific assistance programs that is updated quarterly.

Is Compounded Metformin Legal in Mississippi?

Yes. Compounded metformin prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription is legal in Mississippi. The legal framework comes from Section 503A of the Federal Food, Drug, and Cosmetic Act (FD&C Act), which permits licensed pharmacists or physicians to compound drugs for an identified individual patient based on a valid prescription [4]. Mississippi's State Board of Pharmacy enforces compliance with 503A requirements and requires compounding pharmacies to be licensed in-state or to operate under a reciprocal licensing agreement.

503B outsourcing facilities, which produce larger compounded batches for distribution to healthcare facilities, operate under stricter FDA oversight and are subject to Current Good Manufacturing Practice (CGMP) requirements. Metformin is not on the FDA's 503B "bulk drug substances" list, meaning 503B facilities generally cannot compound metformin for resale outside of a documented shortage or clinical need. The practical implication for Mississippi patients is that their compounded metformin will most likely come from a 503A pharmacy, not a large-scale 503B operation.

One area of regulatory nuance: compounded metformin for longevity or anti-aging indications sits in a gray zone. The FDA has not approved metformin for these indications. A prescriber writing for compounded metformin for longevity must have a documented, patient-specific clinical rationale. The TAME trial (Targeting Aging with Metformin, NCT03077282), a 6-year NIH-funded randomized controlled trial, is currently evaluating metformin 1 to 500 mg/day versus placebo in adults aged 65, 79 for aging-related endpoints [5]. Until TAME reports its primary outcomes, longevity prescribing remains off-label.

Metformin via Telehealth in Mississippi

Telehealth prescribing of metformin is fully legal in Mississippi. The Mississippi State Board of Medical Licensure permits synchronous telemedicine consultations to establish a valid patient-physician relationship, and a controlled substance is not required for metformin, which simplifies the prescribing pathway considerably. No in-person visit is required before a telehealth provider can prescribe metformin in Mississippi as of 2026, provided a proper medical evaluation is completed during the virtual encounter.

HealthRX clinicians can evaluate Mississippi residents via video and, when clinically appropriate, send an electronic prescription for metformin directly to any Mississippi pharmacy or to a mail-order pharmacy of the patient's choosing. The typical workflow takes 24 to 48 hours from consultation to pharmacy-ready prescription.

Patients should arrive at their telehealth visit with recent lab values if available, specifically fasting glucose, HbA1c, a basic metabolic panel (BMP) to assess renal function, and a current medication list. Metformin is contraindicated when the estimated glomerular filtration rate (eGFR) falls below 30 mL/min/1.73 m2 and requires dose review when eGFR falls between 30 to 45 mL/min/1.73 m2, per FDA labeling [6]. A telehealth clinician will request lab work before or shortly after initiating treatment if no recent values are available.

Clinical Evidence: Why Metformin Remains the Standard First-Line Agent

Metformin's position as first-line therapy for type 2 diabetes rests on more than 60 years of clinical use and a body of trial evidence that competitors have not displaced.

The UKPDS 34 trial (N=753 overweight patients with newly diagnosed type 2 diabetes) demonstrated that metformin reduced the risk of any diabetes-related endpoint by 32% (P<0.0023) and all-cause mortality by 36% (P<0.011) compared to conventional diet therapy, without the weight gain or hypoglycemia associated with sulfonylureas [7]. These data, published in The Lancet in 1998, established the mortality benefit that still underpins every major guideline recommendation.

The Diabetes Prevention Program (DPP, N=3,234) showed that metformin 850 mg twice daily reduced progression from prediabetes to type 2 diabetes by 31% over an average follow-up of 2.8 years, compared to placebo [8]. Lifestyle intervention outperformed metformin overall (58% risk reduction), but metformin was substantially more effective than placebo in participants under age 45 and in those with BMI above 35 kg/m2. The DPP Outcomes Study (DPPOS) followed participants for 15 years and found that metformin's effect on diabetes prevention persisted even after the original intervention ended.

The table below summarizes the HealthRX Mississippi Cost-Access Framework, a tool our medical team uses to match Mississippi patients to the most cost-effective metformin access pathway based on their insurance status, eGFR, and clinical indication.

| Patient Profile | Recommended Access Pathway | Estimated Monthly Cost | |---|---|---| | Uninsured, eGFR >45, type 2 DM | Walmart $4 generic program | $4 | | Insured (commercial), type 2 DM | Insurance Tier 1 + verify copay vs. GoodRx | $0, $10 | | Medicare Part D, type 2 DM | Tier 1 Part D formulary | $0, $5 | | Mississippi Medicaid, type 2 DM | PA request with ICD-10 E11 + A1C >7.0% | $0 if approved | | Telehealth patient, prediabetes | Cost Plus Drugs mail-order | ~$2 | | Non-standard dose or form needed | 503A compounding pharmacy | $0, $15 | | eGFR 30, 45, requires monitoring | Standard generic with nephrology co-management | $4, $8 |

Insurance Coverage for Metformin in Mississippi

Most commercial insurance plans sold through the Mississippi health insurance marketplace (Healthcare.gov) include generic metformin as a Tier 1 drug, the lowest-cost tier, with copays typically ranging from $0 to $10 per 30-day supply. Blue Cross and Blue Shield of Mississippi, which holds the dominant market share in the state, lists metformin IR and ER on its preferred formulary at Tier 1 for members with plans that include drug coverage.

Employer-sponsored plans in Mississippi follow similar patterns. Self-insured employer plans governed by ERISA are not required to mirror state insurance mandates, but virtually all include generic metformin given its negligible ingredient cost. Patients whose employer plan charges more than $10 per month for generic metformin should ask their HR benefits team to verify the formulary tier, because an override or exception may be available.

One Mississippi-specific consideration: the state's uninsured rate remained above 12% as of 2024, one of the highest in the nation, according to Kaiser Family Foundation data [9]. For the significant portion of the working-age population without insurance, the discount-program pathways described above are the primary access routes.

Metformin Dosing, Side Effects, and Monitoring: What Mississippi Patients Need to Know

Metformin is taken orally, typically starting at 500 mg once or twice daily with meals to minimize gastrointestinal side effects. The dose is titrated upward over 4 to 8 weeks to a target of 1,500, 2 to 000 mg per day in divided doses, depending on tolerability and glycemic response. Extended-release formulations taken once daily with the evening meal reduce GI side effects for many patients and may improve adherence.

Gastrointestinal symptoms (nausea, diarrhea, abdominal discomfort) affect approximately 25 to 30% of patients starting metformin and typically resolve within the first 4 weeks of treatment. Switching from IR to ER formulation resolves GI intolerance in roughly 50% of those who experience it on IR [10].

Lactic acidosis, the most serious but rare adverse effect, occurs at an estimated rate of 3, 10 cases per 100,000 patient-years based on a Cochrane systematic review of 347 trials [11]. The absolute risk is low and is concentrated almost entirely in patients with eGFR <30 mL/min/1.73 m2, severe hepatic impairment, or acute illness causing tissue hypoperfusion.

Long-term metformin use is associated with reduced vitamin B12 absorption in approximately 7% of patients, with clinically meaningful deficiency in roughly 3%, based on the UKPDS follow-up cohort data. A serum B12 level checked every 2 to 3 years is reasonable for patients on metformin for more than 4 years.

Mississippi-Specific Context: Why Cost and Access Matter More Here

Mississippi carries a disproportionate burden of metabolic disease. According to the CDC's 2023 State Indicator Report on Fruits and Vegetables, Mississippi adults have among the lowest fruit and vegetable consumption rates in the country, a factor independently associated with elevated diabetes risk [12]. The state's obesity prevalence exceeds 39%, ranking it among the top five states nationally by that measure.

Against that backdrop, access to affordable metformin is not a minor convenience issue. A 2019 study in Diabetes Care found that cost-related medication non-adherence among patients with diabetes was associated with a 26% increase in emergency department visits within 12 months [13]. At $4, $8 per month, metformin is affordable for most Mississippi patients even without insurance, but clinicians and patients in the state should be aware that the path to that low price is not always obvious. Many patients default to paying the sticker price or abandoning the prescription entirely without knowing about Walmart's $4 list or Cost Plus Drugs.

Pharmacists in Mississippi are permitted to counsel patients on lower-cost therapeutic equivalents and on discount programs under the state's collaborative pharmacy practice statute. Patients should feel comfortable asking their pharmacist directly: "Is there a cheaper way to fill this?"